Transplacental intrauterine transfusion, a treatment used in HDFN, may increase antibody levels, particularly in those with anterior placenta.
Standard hemoglobin screening may miss iron deficiency that could affect maternal health and newborn blood outcomes, including HDFN.
Courtesy Getty Images ABO incompatibility in HDFN can decrease the risk of sensitization to other red blood cell antibodies, including anti-D, anti-c or anti-Kell. Hemolytic disease of the fetus and ...
Research shows a very low risk of developing antibodies tied to HDFN before 12 weeks, which could change routine care. Early evidence now shows that forgoing RhD immune globulin (RhIG) in most ...
Courtesy Getty Images Learn more about reticulocyte counts in HDFN, which help detect the presence and severity of anemia in a newborn. Infants with hemolytic disease of the fetus and newborn (HDFN) ...
Guidelines included information about when and how treatments like IVIG and IUTs should be administered. There are constantly new suggestions on how alloimmunized pregnancies should be managed. In a ...
Courtesy Getty Images If your infant has a blood transfusion, their blood type may temporarily change, but it will eventually return to its original type. Babies with hemolytic disease of the fetus ...
Understanding how therapies for HDFN affect gut health in newborns may guide safer treatment plans and improve survival rates. Hemolytic disease of the fetus and newborn (HDFN) is closely tied to an ...
Pregnancy-related warm autoantibodies, which some have said may be connected to hemolytic disease of the fetus and newborn (HDFN), appeared not to harm mothers or babies, according to a new study ...
A recent study on blood group antigen distribution in Thailand revealed that blood group O was the most prevalent among participants, followed by B, A and AB. The identification of blood group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results